No data to show
XSTO
NOLA B
Market cap1.48bUSD
Apr 25, Last price
53.00SEK
1D
2.12%
1Q
-4.93%
Jan 2017
101.52%
Name
Nolato AB
Chart & Performance
P/E
21.70
P/S
1.48
EPS
2.44
Div Yield, %
2.83%
Shrs. gr., 5y
0.38%
Rev. gr., 5y
4.06%
Revenues
9.66b
+1.24%
Net income
658m
+51.26%
CFO
1.38b
+76.31%
Dividend
May 07, 20251.5 SEK/sh
Earnings
May 05, 2025
Profile
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, and other industrial sectors in North America, Sweden, Asia, and other Europe region. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; manufactures pipette tips, deep-well plates, microtubes, and PCR products; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic and customized production solutions. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating products; automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for food processing equipment, such as coffee machines and blenders. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was incorporated in 1938 and is headquartered in Torekov, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | 9,664,000 1.24% | 9,546,000 -11.40% | 10,774,000 -7.20% | |||||||
Cost of revenue | 8,780,000 | 9,445,000 | 10,624,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 884,000 | 101,000 | 150,000 | |||||||
NOPBT Margin | 9.15% | 1.06% | 1.39% | |||||||
Operating Taxes | 190,000 | 181,000 | 178,000 | |||||||
Tax Rate | 21.49% | 179.21% | 118.67% | |||||||
NOPAT | 694,000 | (80,000) | (28,000) | |||||||
Net income | 658,000 51.26% | 435,000 -37.59% | 697,000 -39.91% | |||||||
Dividends | (512,000) | (512,000) | ||||||||
Dividend yield | 3.59% | 3.48% | ||||||||
Proceeds from repurchase of equity | 8,000 | 8,000 | ||||||||
BB yield | -0.06% | -0.05% | ||||||||
| Debt | ||||||||||
Debt current | 117,000 | 224,000 | ||||||||
Long-term debt | 2,050,000 | 2,023,000 | ||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 1,793,000 | 536,000 | 236,000 | |||||||
Net debt | (672,000) | 1,476,000 | 1,233,000 | |||||||
| Cash flow | ||||||||||
Cash from operating activities | 1,377,000 | 781,000 | 406,000 | |||||||
CAPEX | (426,000) | (455,000) | ||||||||
Cash from investing activities | (636,000) | (444,000) | (451,000) | |||||||
Cash from financing activities | (798,000) | (631,000) | (487,000) | |||||||
FCF | 696,000 | (362,000) | (959,000) | |||||||
| Balance | ||||||||||
Cash | 672,000 | 688,000 | 1,011,000 | |||||||
Long term investments | 3,000 | 3,000 | ||||||||
Excess cash | 188,800 | 213,700 | 475,300 | |||||||
Stockholders' equity | 4,683,000 | 4,904,000 | ||||||||
Invested Capital | 7,531,000 | 7,367,300 | 7,015,700 | |||||||
ROIC | 9.32% | |||||||||
ROCE | 11.37% | 1.33% | 1.93% | |||||||
| EV | ||||||||||
Common stock shares outstanding | 269,377 | 269,377 | 269,377 | |||||||
Price | 54.20 2.46% | 52.90 -3.20% | 54.65 -49.35% | |||||||
Market cap | 14,600,238 2.46% | 14,250,048 -3.20% | 14,721,458 -49.24% | |||||||
EV | 13,928,238 | 15,726,048 | 15,954,458 | |||||||
EBITDA | 884,000 | 697,000 | 694,000 | |||||||
EV/EBITDA | 15.76 | 22.56 | 22.99 | |||||||
Interest | 70,000 | 56,000 | ||||||||
Interest/NOPBT | 69.31% | 37.33% | ||||||||